Cited by 37Cancer-related Molecular PathwaysProtein Kinase Regulation and GTPase SignalingSignaling Pathways in Disease

B55α PP2A Holoenzymes Modulate the Phosphorylation Status of the Retinoblastoma-related Protein p107 and Its Activation

Open access
Jayadeva, Girish, Kurimchak, Alison, Garriga, Judit, Sotillo, Elena, Davis, Anthony J., Haines, Dale S., Mumby, Marc, Graña, Xavier·2010·Journal of Biological Chemistry

Abstract

Pocket proteins negatively regulate transcription of E2F-dependent genes and progression through the G(0)/G(1) transition and the cell cycle restriction point in G(1). Pocket protein repressor activities are inactivated via phosphorylation at multiple Pro-directed Ser/Thr sites by the coordinated action of G(1) and G(1)/S cyclin-dependent kinases. These phosphorylations are reversed by the action of two families of Ser/Thr phosphatases: PP1, which has been implicated in abrupt dephosphorylation of retinoblastoma protein (pRB) in mitosis, and PP2A, which plays a role in an equilibrium that counteracts cyclin-dependent kinase (CDK) action throughout the cell cycle. However, the identity of the trimeric PP2A holoenzyme(s) functioning in this process is unknown. Here we report the identification of a PP2A trimeric holoenzyme containing B55α, which plays a major role in restricting the phosphorylation state of p107 and inducing its activation in human cells. Our data also suggest targeted selectivity in the interaction of pocket proteins with distinct PP2A holoenzymes, which is likely necessary for simultaneous pocket protein activation.

Integrity signals

Registry

Crossref · 10.1074/jbc.m110.162354

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tau and p107 share very little overlap in the residues required for B55α binding.

    “It is conceivable that this acidic top may use substrate-specific sequences to discriminate between its various binding partners, as Tau and p107 have been shown to share very little overlap between residues necessary for binding (Jayadeva et al., 2010).”
  • A single aspartic acid to lysine mutation in the B55α top surface abolishes binding to p107.

    “Binding of B55α to one of its other substrates, p107, has also been shown to be abrogated by a single aspartic acid to lysine mutation in the top surface.”
  • PP2A removes phosphate from pocket proteins throughout the cell cycle; pRB is a target of PP2A/PR70, and p107, p130 and probably pRB are targets of PP2A/B55α.

    “As previously mentioned, PP2A can dephosphorylate pocket proteins in all phases in cell cycle, with pRB as a target of PP2A/PR70 and p107, p130 and likely pRB as targets of PP2A/B55α (Jayadeva et al., 2010; Kurimchak et al., 2013; Magenta et al., 2008).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jayadeva, G., Kurimchak, A., Garriga, J., Sotillo, E., Davis, A. J., Haines, D. S., Mumby, M., & Graña, X.
Affiliations
  • Temple University (US)
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Graña, Xavier
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2010-09
Volume
285
Issue
39
Pages
29863-29873
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1998903301
Cited by
37
References
29
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 3 · 2019: 4 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 4 · 2013: 6 · 2012: 4
FWCI
1.58
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (CA095569, P01CA095569)
  • National Institute of General Medical Sciences (R01GM086560)
  • National Institute of Allergy and Infectious Diseases (K02 AI01823, K02AI001823)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
PP2A holoenzyme, p107, retinoblastoma-related protein, pocket proteins, protein phosphorylation, dephosphorylation, cyclin-dependent kinases, cell cycle regulation, G1/S transition
MeSH terms
Cell Cycle, Humans, Phosphorylation, Transcription, Genetic, Cyclin-Dependent Kinases, Holoenzymes, Cell Line, Tumor, E2F Transcription Factors, Retinoblastoma-Like Protein p107, Protein Phosphatase 2, Protein Multimerization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review